0R2S Stock Overview
Operates as a medical technology company. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Stryker Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$392.61 |
| 52 Week High | US$406.70 |
| 52 Week Low | US$315.97 |
| Beta | 0.96 |
| 1 Month Change | 9.79% |
| 3 Month Change | 6.96% |
| 1 Year Change | 15.15% |
| 3 Year Change | 57.42% |
| 5 Year Change | 80.39% |
| Change since IPO | 366.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0R2S | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0.1% | 2.7% | 2.0% |
| 1Y | 15.2% | -4.0% | 10.8% |
Return vs Industry: 0R2S exceeded the UK Medical Equipment industry which returned -4% over the past year.
Return vs Market: 0R2S exceeded the UK Market which returned 10.8% over the past year.
Price Volatility
| 0R2S volatility | |
|---|---|
| 0R2S Average Weekly Movement | 2.7% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.8% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0R2S has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0R2S's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 52,000 | Kevin Lobo | www.stryker.com |
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Stryker Corporation Fundamentals Summary
| 0R2S fundamental statistics | |
|---|---|
| Market cap | US$149.17b |
| Earnings (TTM) | US$2.99b |
| Revenue (TTM) | US$22.60b |
49.8x
P/E Ratio6.6x
P/S RatioIs 0R2S overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0R2S income statement (TTM) | |
|---|---|
| Revenue | US$22.60b |
| Cost of Revenue | US$8.05b |
| Gross Profit | US$14.55b |
| Other Expenses | US$11.55b |
| Earnings | US$2.99b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.85 |
| Gross Margin | 64.37% |
| Net Profit Margin | 13.25% |
| Debt/Equity Ratio | 59.1% |
How did 0R2S perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield41%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 13:13 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Stryker Corporation is covered by 71 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Richard Purkiss | Atlantic Equities LLP |
| Jeffrey Johnson | Baird |